<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17997" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Atypical Squamous Cells of Undetermined Significance</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ndifon</surname>
            <given-names>Cornelia O.</given-names>
          </name>
          <aff>Johns Hopkins Programme</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Al-Eyd</surname>
            <given-names>Ghaith</given-names>
          </name>
          <aff>Nova Southeastern University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Cornelia Ndifon declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ghaith Al-Eyd declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17997.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Atypical squamous cells of undetermined significance (ASC-US) is a category of cervical epithelial cell abnormalities described by the Bethesda system for reporting cervical cytology. It refers to abnormal cytologic changes that are suggestive of the squamous intraepithelial lesion (SIL) but are qualitatively and quantitatively less than those of a definitive SIL diagnosis. Based on the patient's age and the estimated risk of possible underlying neoplastic lesions, an ASC-US report requires further follow-up by doing repeat cytology and HPV tests to guide the management of potential precancerous/cancerous cervical lesions. This activity reviews the evaluation and management of ASC-US and highlights the role of the interprofessional team in this process.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Explain the term "ASC-US" and identify its etiology.</p></list-item><list-item><p>Describe the diagnostic workup tests used to evaluate a patient with a cervical cytology report of ASC-US.</p></list-item><list-item><p>Outline the management of a patient with a cervical cytology report of ASC-US, based on the most recent practice guidelines.</p></list-item><list-item><p>Explain the importance of collaboration and communication among the interprofessional team to ensure a thorough evaluation and management of a patient with a cervical cytology report of ASC-US.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17997&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17997">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17997.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Atypical squamous cells of undetermined significance (ASC-US) is a term used to report a category of cervical epithelial cell abnormalities described by the Bethesda system for reporting cervical cytology. It refers to abnormal cytologic changes that are suggestive of the squamous intraepithelial lesion (SIL) but are qualitatively and quantitatively less than those of a definitive SIL diagnosis.<xref ref-type="bibr" rid="article-17997.r1">[1]</xref>&#x000a0;The clinical significance of ASC-US is based on the fact that this cytology finding is suggestive of a varying degree of SIL. Nearly 10% to 20% of patients with ASC-US prove to have a varying degree of cervical intraepithelial neoplasia (CIN), which are distinctive precursor lesions of cervical squamous cell carcinoma.<xref ref-type="bibr" rid="article-17997.r2">[2]</xref></p>
        <p>About a decade ago, cervical cancer was the third most common cancer in women worldwide,&#x000a0;and it was ranked as the first most common cancer in women in 42 low-resourced countries.<xref ref-type="bibr" rid="article-17997.r3">[3]</xref>&#x000a0;However,&#x000a0;the explained link between persistent infection with carcinogenic human papillomavirus (HPV) and the development of cervical cancer has paved the way for the advancement of primary and secondary prevention of this type of cancer. The currently used preventive measures include primary prevention by HPV vaccination and secondary prevention&#x000a0;through cervical screening programs, patient's follow-up, and treatment of precursor lesions.<xref ref-type="bibr" rid="article-17997.r4">[4]</xref></p>
        <p>In developed countries such as United States, United Kingdom, and Canada, widespread availability and access to cervical cancer screening have led to a significant reduction in both incidence and mortality from cervical cancer.<xref ref-type="bibr" rid="article-17997.r5">[5]</xref><xref ref-type="bibr" rid="article-17997.r6">[6]</xref><xref ref-type="bibr" rid="article-17997.r7">[7]</xref><xref ref-type="bibr" rid="article-17997.r8">[8]</xref>&#x000a0;In the United States, the incidence of cervical cancer cases has dropped to 7.4 per 100,000, while deaths from invasive cervical cancer have dropped to 2.8 per 100,000 women.<xref ref-type="bibr" rid="article-17997.r9">[9]</xref><xref ref-type="bibr" rid="article-17997.r10">[10]</xref><xref ref-type="bibr" rid="article-17997.r11">[11]</xref>&#x000a0;A late diagnosis of invasive cervical cancer has a 100 percent mortality rate. The importance of screening in the prevention of cervical cancer is that precancerous stages are slow-growing and amenable to treatment.<xref ref-type="bibr" rid="article-17997.r12">[12]</xref><xref ref-type="bibr" rid="article-17997.r13">[13]</xref>&#x000a0;Active screening and treatment of women for precancerous lesions, particularly in developing countries, have a very high chance of total elimination of deaths from cervical cancer.<xref ref-type="bibr" rid="article-17997.r14">[14]</xref><xref ref-type="bibr" rid="article-17997.r5">[5]</xref>&#x000a0;A more recent study estimated the worldwide age-standardized incidence rate&#x000a0;of cervical cancer to be&#x000a0;13&#x000b7;1 (6.4 for Northern&#x000a0;America) per 100,000 women-years and an age-standardized mortality rate of 6&#x000b7;9 (1.9 for Northern America) per 100,000. In the same study, cervical cancer was ranked as the worldwide fourth most common cancer among women after breast cancer, colorectal cancer, and lung cancer.<xref ref-type="bibr" rid="article-17997.r15">[15]</xref></p>
        <p>Though it has been previously theorized that alpha-1 antitrypsin deficiency may be a genetic predisposition, this is not yet confirmed.<xref ref-type="bibr" rid="article-17997.r16">[16]</xref>&#x000a0;Rather, ample scientific evidence suggests that certain high-risk Human papillomaviruses (hrHPV)&#x000a0;cause over 90% of cervical cancers, with 50 to 73.8% attributed to HPV 16 strain and 12 to 16.4 % attributed to HPV 18.<xref ref-type="bibr" rid="article-17997.r17">[17]</xref><xref ref-type="bibr" rid="article-17997.r18">[18]</xref>&#x000a0;The long-standing model of diagnosis has been by cytology using the Papanicolaou smear (Pap test) and biopsy, and most recently by liquid-based cytology (LBC).<xref ref-type="bibr" rid="article-17997.r19">[19]</xref><xref ref-type="bibr" rid="article-17997.r20">[20]</xref>&#x000a0;Other methods of diagnosis include HPV&#x000a0;DNA test and colposcopy.<xref ref-type="bibr" rid="article-17997.r21">[21]</xref><xref ref-type="bibr" rid="article-17997.r22">[22]</xref></p>
        <p>Women that have ever been sexually active&#x000a0;are at risk of developing cervical cancer; however, there are women with a greater risk profile than others. Risk factors commonly associated with the development of cervical cancer&#x000a0;include younger age at sexual debut, multiple concurrent sexual partners, chronic intense smoking, HIV infection, and persistent infection with high-risk HPV. Though the Pap test dates back to the late 1940s, it has not been fully adopted and utilized in resource-limited settings for several reasons, including high cost and delay in getting results. Very low rates of Pap smear have been reported in resource-limited countries, including Jamaica at 15% and Nicaragua at 20% national coverage. In some Asian and African countries, Pap testing rates are even lower, or it does not even exist, compared to Jamaica.<xref ref-type="bibr" rid="article-17997.r23">[23]</xref>&#x000a0;In other countries, at the time when cervical screening programs were not implemented, opportunistic Pap smear screening tests were used instead, but the rate was&#x000a0;also remarkably low.<xref ref-type="bibr" rid="article-17997.r24">[24]</xref></p>
        <p>Visual inspection of the ectocervix is the new way of screening, with immediate results and successful treatment of most of the identified precancerous lesions.<xref ref-type="bibr" rid="article-17997.r25">[25]</xref>&#x000a0;Negative cervical cytology is reported as "negative for intraepithelial lesion or malignancy" (Negative/NILM).&#x000a0;Squamous cell abnormalities that can be detected by cervical cytology include ASC-US, atypical squamous cells-high-grade cannot be excluded (ASC-H), low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial session (HSIL), and invasive squamous cancer. Glandular cell abnormalities include atypical glandular cells (AGC), including endocervical&#x000a0;and endometrial cells (not otherwise specified or favor neoplastic), endocervical adenocarcinoma in situ (AIS), and adenocarcinoma. This activity will improve the understanding of what ASC-US is and the implications and management of ASC-US diagnosis.<xref ref-type="bibr" rid="article-17997.r26">[26]</xref><xref ref-type="bibr" rid="article-17997.r27">[27]</xref><xref ref-type="bibr" rid="article-17997.r21">[21]</xref><xref ref-type="bibr" rid="article-17997.r28">[28]</xref></p>
      </sec>
      <sec id="article-17997.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Cervical cancer is not a sexually transmitted infection, but it develops from precursor lesions (CIN)&#x000a0;that are predisposed by a persistent infection&#x000a0;with a common sexually transmitted pathogen, the HPV. There are over 200 species of human papillomavirus. Researchers have identified 13 hrHPV viral strains that cause human cancers, of which HPV 16 and HPV 18 cause about 70 percent of cervical cancers, and more so in HIV-infected women.<xref ref-type="bibr" rid="article-17997.r29">[29]</xref><xref ref-type="bibr" rid="article-17997.r30">[30]</xref>&#x000a0;The atypical squamous cells&#x000a0;seen in cervical cytology may be related to&#x000a0;HPV infection and neoplasia. They are just cytologic mimics caused by&#x000a0;inflammation, air drying, atrophy with degeneration, and other artifacts. One study of the U.S. cervical screening programs&#x000a0;showed about 50% of women with atypical squamous cells are infected with HrHPV. In contrast, the other noninfected women are not at increased cancer risk.<xref ref-type="bibr" rid="article-17997.r2">[2]</xref></p>
        <p>Other studies have demonstrated a high prevalence of hrHPV in patients with ASC-US; one study in Brazil analyzed 1,340 liquid-based cytology specimens and found out that 64% of ASC-US specimens harbored hrHPV.<xref ref-type="bibr" rid="article-17997.r31">[31]</xref>&#x000a0;In two separate studies, Mai Nishimura reported identifying hrHPV in 81 % of patients with ASC-US. In contrast, Ming Guo and colleagues reported a hrHPV 16/18 incidence rate of 37% in their ASC-US patient cohort, while one Mexican study found an incidence rate of 11.2 percent.<xref ref-type="bibr" rid="article-17997.r32">[32]</xref><xref ref-type="bibr" rid="article-17997.r33">[33]</xref><xref ref-type="bibr" rid="article-17997.r34">[34]</xref>&#x000a0;In another study in Turkey, 129 women with abnormal Pap smears were screened for hrHPV positivity, 94 had ASC-US diagnosis, and 94% of those had a hrHPV.<xref ref-type="bibr" rid="article-17997.r35">[35]</xref></p>
      </sec>
      <sec id="article-17997.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Cervical precancer lesions are slow-growing and are commonest between the ages of 35 and 45 years but can be seen more frequently in HIV-positive women between the ages of 25 and 35. With the persistence of hrHPV infection over the years or decades, actual cancer peaks after the age of 50 years.<xref ref-type="bibr" rid="article-17997.r36">[36]</xref>&#x000a0;We call ASC-US today originally described by Papanicolaou as atypical pathology, and it is a cytological nomenclature.<xref ref-type="bibr" rid="article-17997.r19">[19]</xref>&#x000a0;The original laboratory technicians who worked on smears reported them simply as normal, atypical, or suspicious/malignant.<xref ref-type="bibr" rid="article-17997.r19">[19]</xref>&#x000a0;ASC-US, therefore, represents a mix of squamous epithelial cells at different stages of transitioning from the lowest risk atypia to the worst form of precancer, with some harboring the potential to revert to normalcy.<xref ref-type="bibr" rid="article-17997.r32">[32]</xref></p>
        <p>The histological classification known as cervical intraepithelial neoplasia or CIN is a three-tier grading of CIN that corresponds to the number of layers of epithelial cells affected by atypia.<xref ref-type="bibr" rid="article-17997.r36">[36]</xref><xref ref-type="bibr" rid="article-17997.r37">[37]</xref>&#x000a0;The CIN classification replaces the dysplasia terminology, with CIN 1, CIN 2, and CIN 3 being equivalent to mild dysplasia, moderate dysplasia, and severe dysplasia, respectively. The dysplasia descriptions are, however, no longer in use. There modified Bethesda system of cytological classification divides atypical squamous cells (ASC) into atypical squamous cells of undetermined significance (ASC-US), and atypical squamous cells-high-grade cannot be excluded (ASC-H).<xref ref-type="bibr" rid="article-17997.r38">[38]</xref><xref ref-type="bibr" rid="article-17997.r39">[39]</xref></p>
        <p>ASC-US is a common diagnostic category considered to be&#x000a0;a difficult and grey zone diagnosis between negative and a confirmed SIL.<xref ref-type="bibr" rid="article-17997.r36">[36]</xref><xref ref-type="bibr" rid="article-17997.r39">[39]</xref>&#x000a0;Follow-up and further analyses of ASC-US results have not only identified LSIL cells but HSIL also.<xref ref-type="bibr" rid="article-17997.r40">[40]</xref>&#x000a0;By the Bethesda system, ASC-US/ASC-H taken together is of lesser risk compared to LSIL, which is the equivalent of CIN1 by histology and HSIL (CIN 2/3).<xref ref-type="bibr" rid="article-17997.r41">[41]</xref><xref ref-type="bibr" rid="article-17997.r36">[36]</xref><xref ref-type="bibr" rid="article-17997.r42">[42]</xref><xref ref-type="bibr" rid="article-17997.r43">[43]</xref>&#x000a0;Different studies have reported the incidence of ASC-US to be as low as 2.5% in one Japanese study, 4.1% in one US study, 5.8% in another U.S. study, 7.4% in Bosnia, and as high as 19.1% in another Japanese study.<xref ref-type="bibr" rid="article-17997.r32">[32]</xref><xref ref-type="bibr" rid="article-17997.r42">[42]</xref><xref ref-type="bibr" rid="article-17997.r44">[44]</xref><xref ref-type="bibr" rid="article-17997.r45">[45]</xref><xref ref-type="bibr" rid="article-17997.r46">[46]</xref></p>
      </sec>
      <sec id="article-17997.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Atypical squamous cells that are related to an underlying SIL&#x000a0;are&#x000a0;associated with&#x000a0;HPV infection. Following the initial acquisition of hrHPV, there is an inflammatory response that resolves after a short time. The chronic&#x000a0;cases progress to more severe persistent infection associated with nuclear and cytoplasmic changes. In the presence of hrHPV 16 and 18, the viral genes E6 and E7&#x000a0;are thought to encode viral proteins in the infected squamous cells that promote the degradation of tumor suppressor gene proteins p53 and Rb respectively, resulting in malignant&#x000a0;transformation.<xref ref-type="bibr" rid="article-17997.r26">[26]</xref><xref ref-type="bibr" rid="article-17997.r47">[47]</xref>&#x000a0;Mahira Jahic and Elmir Jahic&#x000a0;did a prospective analysis of 1,784 Pap smears and found that, out of 254 abnormal smears, overall, 74% persisted, 8% regressed, and 18% progressed to the worse stage.<xref ref-type="bibr" rid="article-17997.r46">[46]</xref>&#x000a0;Studies using immunohistochemistry have associated the loss of certain capsid proteins in ASC-US specimens with progression to a more severe form of precancer. Eun Young Ki and colleagues showed that detection of HPV serotypes 16 and 18 in the absence of HPV L1 capsid expression predicted worsening of precancer.<xref ref-type="bibr" rid="article-17997.r48">[48]</xref>&#x000a0;HIV positivity has also been known to promote HPV persistence and associated with a higher incidence of ASC-US.<xref ref-type="bibr" rid="article-17997.r25">[25]</xref><xref ref-type="bibr" rid="article-17997.r49">[49]</xref>&#x000a0;Furthermore, a low CD4 count and not being on antiretroviral therapy were associated with the persistence of HPV infection.<xref ref-type="bibr" rid="article-17997.r50">[50]</xref><xref ref-type="bibr" rid="article-17997.r49">[49]</xref><xref ref-type="bibr" rid="article-17997.r31">[31]</xref><xref ref-type="bibr" rid="article-17997.r51">[51]</xref><xref ref-type="bibr" rid="article-17997.r46">[46]</xref><xref ref-type="bibr" rid="article-17997.r47">[47]</xref><xref ref-type="bibr" rid="article-17997.r12">[12]</xref></p>
      </sec>
      <sec id="article-17997.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>ASC-US is a cytopathology term that implies cervical epithelial cell abnormalities described by the Bethesda system for reporting cervical cytology. It refers to abnormal cytologic changes that are suggestive of SIL but are qualitatively and quantitatively less than those of a definitive SIL diagnosis.<xref ref-type="bibr" rid="article-17997.r1">[1]</xref>&#x000a0;The&#x000a0;morphologic criteria of ASC-US include cells that have the shape and size of superficial or intermediate squamous cells with enlarged nuclei 2.5 to 3 times the area of those of normal intermediate squamous cells,&#x000a0;slightly increased nucleo-cytoplasmic ratio,&#x000a0;with minimum hyperchromatism and&#x000a0;irregular chromatin. The cytoplasm may show halo and atypical parakeratosis (dense orangeophilic). These criteria may vary slightly among different laboratories due to differences in slide preparation and staining techniques.<xref ref-type="bibr" rid="article-17997.r52">[52]</xref><xref ref-type="bibr" rid="article-17997.r53">[53]</xref><xref ref-type="bibr" rid="article-17997.r54">[54]</xref>&#x000a0;The distinction between a true premalignant lesion and a neoplastic one is based on the number, type, and severity of change both in the nucleus and cytoplasm. An ASC-US smear may also show mitosis, blurring of cytoplasmic borders, binucleation, and corneal pearls. Other histologic changes include squamous epithelial giant cells and parakeratosis.<xref ref-type="bibr" rid="article-17997.r55">[55]</xref>&#x000a0;Hyperchromasia and enlargement of nucleoli suggest a progression from a &#x02018;mere&#x02019; ASC-US to LSIL/CIN 1 plus.<xref ref-type="bibr" rid="article-17997.r56">[56]</xref><xref ref-type="bibr" rid="article-17997.r57">[57]</xref>&#x000a0;Histologically and&#x000a0;as described earlier, the CIN histological classification is a three-tier grading of CIN that corresponds to the number of layers of epithelial cells affected by atypia.</p>
      </sec>
      <sec id="article-17997.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>ASC-US is not a clinical diagnosis. A woman receiving an ASC-US report from Pap test is most often asymptomatic and is most likely identified through a population-based screening. Alternatively, she may present with bloody, offensive, and or watery vaginal discharge, lower backache, or signs of urinary tract infection and be diagnosed opportunistically.<xref ref-type="bibr" rid="article-17997.r27">[27]</xref>&#x000a0;The physical examination evaluates the general health of the patient and checks for possible&#x000a0;signs related to pathologies that may underlie the cytologic changes of ASC-US.</p>
        <p>Considering that a late diagnosis or advanced invasive cervical cancer has no remedy, it is important to consider the risk factors that predispose women to&#x000a0;develop&#x000a0;this cancer and use that as a guide to determine the screening status of women in their care.<xref ref-type="bibr" rid="article-17997.r58">[58]</xref>&#x000a0;Risk factors for cervical cancer include lower age at sexual debut, multiple sexual partners, and&#x000a0;sexually transmitted infections, including hrHPV and HIV. Also, women who have never had an initial Pap test were observed to present with a more severe form of a precancerous lesion or full-blown cancer.<xref ref-type="bibr" rid="article-17997.r58">[58]</xref>&#x000a0;Prolonged and intense smoking has also been linked to an increased risk of developing cervical cancer.<xref ref-type="bibr" rid="article-17997.r59">[59]</xref></p>
      </sec>
      <sec id="article-17997.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Cervical cancer screening in women between the age of 21 and 65 years is supported by the American College of Obstetricians and Gynecologists (ACOG), American Cancer Society (ACS), U.S Preventive Services Task Force (USPSTF), and the U.S. Food and Drug Administration (FDA).<xref ref-type="bibr" rid="article-17997.r6">[6]</xref><xref ref-type="bibr" rid="article-17997.r14">[14]</xref>&#x000a0;Studies have shown that regular and consistent screening of women for cervical cancer reduces invasive cervical cancer incidence and deaths.<xref ref-type="bibr" rid="article-17997.r7">[7]</xref>&#x000a0;Any sexually active woman presenting in the outpatient department with gynecologic or perianal symptoms, including abnormal vaginal bleeding, vaginal discharge, dysuria, or vaginal itching, should undergo triage testing.<xref ref-type="bibr" rid="article-17997.r44">[44]</xref><xref ref-type="bibr" rid="article-17997.r34">[34]</xref>&#x000a0;Immunocompetent and asymptomatic women between the ages of 21 and 29 are to be screened once every three years by cytology alone. In the older age groups of 30 to 65 years, where HPV persistence may spell problems, HrHPV testing alone or co-testing (HrHPV and cytology)&#x000a0;is also recommended every 5 years in addition to the option of screening by cytology alone every 3 years.<xref ref-type="bibr" rid="article-17997.r8">[8]</xref><xref ref-type="bibr" rid="article-17997.r6">[6]</xref><xref ref-type="bibr" rid="article-17997.r60">[60]</xref>&#x000a0;Screening is not recommended for women below age 21 because most HPV infections are transient or clear completely. Women older than 65 years can cease surveillance screening if they have consistently been previously negative.</p>
        <p>Triage testing involves cytology with Pap test or LBC, visual inspection with acetic acid (VIA) plus colposcopy, HPV DNA, or any combination as recommended in the setting where one works.<xref ref-type="bibr" rid="article-17997.r34">[34]</xref><xref ref-type="bibr" rid="article-17997.r61">[61]</xref><xref ref-type="bibr" rid="article-17997.r34">[34]</xref>&#x000a0;Triage testing is specifically relevant to a patient with an ASC-US diagnosis because it enables further delineation of an ASC-US result into a true NILM, LSIL, or HSIL.<xref ref-type="bibr" rid="article-17997.r62">[62]</xref><xref ref-type="bibr" rid="article-17997.r44">[44]</xref><xref ref-type="bibr" rid="article-17997.r32">[32]</xref><xref ref-type="bibr" rid="article-17997.r47">[47]</xref></p>
        <p>Initially, a bimanual and speculum vaginal examination is done. Either Pap test is done alone or together with hrHPV DNA assay, or VIA is done alone or in combination with hrHPV DNA, or hrHPV DNA is done alone (primary HPV testing).<xref ref-type="bibr" rid="article-17997.r60">[60]</xref><xref ref-type="bibr" rid="article-17997.r63">[63]</xref>&#x000a0;The combination of cytology and HPV DNA testing is advocated for because HPV DNA testing is more sensitive than cytological analysis alone. At the same time, however, the very infrequent occurrence of HPV negative/cytology-positive cancers has highlighted the importance of co-testing.<xref ref-type="bibr" rid="article-17997.r64">[64]</xref><xref ref-type="bibr" rid="article-17997.r44">[44]</xref><xref ref-type="bibr" rid="article-17997.r32">[32]</xref><xref ref-type="bibr" rid="article-17997.r60">[60]</xref></p>
        <p>Visual inspection with acetic acid involves the application of 3% to 5% dilutes acetic acid for one minute on the ectocervix.<xref ref-type="bibr" rid="article-17997.r25">[25]</xref>&#x000a0;Aceto-whitening of ectocervical lesions is caused by the high absorption of acetic acid by protein-rich precancer cells.<xref ref-type="bibr" rid="article-17997.r65">[65]</xref>&#x000a0;Good visualization of the post-application cervix is achieved with a handheld bright light or colposcope. VIA studies are reported as VIA-negative, VIA-positive, or suspicious for cancer. Colposcopy-guided cervical biopsies are usually done for VIA positive and suspicious for cancer patients.<xref ref-type="bibr" rid="article-17997.r66">[66]</xref><xref ref-type="bibr" rid="article-17997.r67">[67]</xref><xref ref-type="bibr" rid="article-17997.r25">[25]</xref></p>
      </sec>
      <sec id="article-17997.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The variable progression following the diagnosis of ASC-US poses a management challenge. There is&#x000a0;a possibility of overtreatment, and at the same time, also the risk of progression to higher grade precancerous lesions or even invasive cancer with conservative treatment, especially if close follow-up is not carried out.<xref ref-type="bibr" rid="article-17997.r32">[32]</xref>&#x000a0;J Melnikow and colleagues&#x000a0;found, in a meta-analysis, that 68% of ASC-US regressed to normal by 24 months, while 7.13 % of ASC-US progressed to a worse grade SIL in the same period.<xref ref-type="bibr" rid="article-17997.r68">[68]</xref></p>
        <p>The diagnosis of ASC-US begins to gain clinical significance when it is associated with a positive hrHPV diagnosis. Both reflex HPV DNA testing and co-testing have reported a high incidence of hrHPV in ASC-US specimens.<xref ref-type="bibr" rid="article-17997.r60">[60]</xref><xref ref-type="bibr" rid="article-17997.r34">[34]</xref>&#x000a0;The 'U' in ASC-US stands for 'undetermined' significance because it is unclear how much of the ASC-US may resolve to become negative and how much would persist and progress to become low- or high-grade squamous intraepithelial lesion.<xref ref-type="bibr" rid="article-17997.r68">[68]</xref>&#x000a0;Also, the main factors responsible for persistence are not fully understood, though hrHPV infection is known to persist more in HIV positive patients compared to HIV negative patients, resulting in a higher incidence of invasive cervical cancer in HIV positive patients.<xref ref-type="bibr" rid="article-17997.r69">[69]</xref><xref ref-type="bibr" rid="article-17997.r25">[25]</xref></p>
        <p>An initial ASC-US may warrant no further management except to repeat Pap cytology alone or do an acetic acid-guided visual inspection (VIA)&#x000a0;with colposcopy or in combination with HPV genotyping (DNA or mRNA) where feasible.<xref ref-type="bibr" rid="article-17997.r70">[70]</xref><xref ref-type="bibr" rid="article-17997.r25">[25]</xref> Persistent ASC-US, including ASC-H, calls for a thorough analysis (triaging) and intervention, including referral for colposcopy.<xref ref-type="bibr" rid="article-17997.r40">[40]</xref><xref ref-type="bibr" rid="article-17997.r10">[10]</xref>&#x000a0;Eun Young Ki and colleagues define ASC-US persistence at 12-month repeat cytology or serial ASC-US reports.<xref ref-type="bibr" rid="article-17997.r48">[48]</xref>&#x000a0;Studies have shown that HPV DNA testing prior to colposcopy in women with persistent ASC-US provided improved diagnostic sensitivity compared to a CIN 2+ diagnosis.<xref ref-type="bibr" rid="article-17997.r71">[71]</xref></p>
        <p>The American Society for Colposcopy and Cervical Pathology (ASCCP) has recently published (in April 2020) the 2019 ASCCP risk-based management guidelines for abnormal cervical cancer screening tests and cancer precursors.&#x000a0;One of the essential changes from prior management guidelines is that patient's risk of CIN3+, determined by current test results and past history (including unknown history),&#x000a0;has become a key factor on which recommendations of colposcopy, treatment, or surveillance are based.<xref ref-type="bibr" rid="article-17997.r28">[28]</xref>&#x000a0;</p>
        <p>In patients younger than 25 years with LSIL, ASC-US HPV-positive, or ASC-US without HPV testing, repeat cytology at 1 year is preferred, and if the result is&#x000a0;NILM/ASC-US/LSIL, another repeat cytology is needed in 1 year, after that if the result is negative, then routine age-based screening&#x000a0;is&#x000a0;resumed. If HPV testing was&#x000a0;first done for a patient with ASC-US, and the test was negative, there would be no need for the repeat cytology described above, and routine age-based screening&#x000a0;could be directly resumed. Colposcopy is indicated if the first one-year repeat cytology shows HSIL/ASC-H/AGC/AIS, and also&#x000a0;when the second one-year repeat cytology shows ASC-US or more severe lesions.<xref ref-type="bibr" rid="article-17997.r28">[28]</xref></p>
        <p>As per&#x000a0;the&#x000a0;new 2019 ASCCP guidelines, practitioners&#x000a0;should&#x000a0;start&#x000a0;using&#x000a0;CIN3+ risk estimates (based on HPV testing/co-testing and past history) when a patient reaches the age of 25 years.&#x000a0;Previously (before the recent guidelines update), patients&#x000a0;aged&#x000a0;25 years and older&#x000a0;with ASCUS have two management options, one option is to do HPV testing (preferred), and if the test is positive, colposcopy is indicated, while&#x000a0;patients with negative HPV test will have repeat cytology in three years. The second option is to repeat the cytology in one year, and if an abnormality is detected, then colposcopy is indicated. If the one-year repeat cytology&#x000a0;is&#x000a0;negative, then the patient can return to&#x000a0;routine age-based screening. But&#x000a0;per the new guidelines, a colposcopy can be deferred for certain patients if they have only minor screening abnormalities indicating HPV infection, provided that&#x000a0;the risk of having CIN3+ is low. For example, a patient who tested&#x000a0;HPV positive&#x000a0;with low-grade cytologic abnormalities (LSIL/ASC-US), and has a past history of documented negative screening HPV test or co-test, can now be managed by repeating HPV testing or co-testing at 1 year. Practitioners can start managing their patients based on these new 2019 ASCCP guidelines using the tables&#x000a0;of Egemen et al.&#x000a0;or by using an app or website that will be designed&#x000a0;and made available at the ASCCP website.<xref ref-type="bibr" rid="article-17997.r28">[28]</xref><xref ref-type="bibr" rid="article-17997.r72">[72]</xref></p>
        <p>SIL treatment options include ablation methods such as cryotherapy&#x000a0;or thermocoagulation, while HSIL (CIN 2+) is best treated by large loop excision of the transformation zone/loop electrosurgical excision procedure (LLETZ/LEEP) or laser or cold knife conization in cases of adenocarcinoma in-situ (AIS).<xref ref-type="bibr" rid="article-17997.r73">[73]</xref><xref ref-type="bibr" rid="article-17997.r74">[74]</xref><xref ref-type="bibr" rid="article-17997.r75">[75]</xref><xref ref-type="bibr" rid="article-17997.r76">[76]</xref><xref ref-type="bibr" rid="article-17997.r77">[77]</xref><xref ref-type="bibr" rid="article-17997.r12">[12]</xref><xref ref-type="bibr" rid="article-17997.r78">[78]</xref>&#x000a0;During cryotherapy, pressurized gas, either carbon dioxide or nitrous oxide, is used to freeze acetowhite lesions that are 3 to 5 mm deep under normal light or colposcopic guidance.<xref ref-type="bibr" rid="article-17997.r13">[13]</xref>&#x000a0;Thermal coagulation is the burning of acetowhite areas depicting precancerous lesions. Both heat and cold coagulation cause tissue necrosis with minimal or no systemic complications.<xref ref-type="bibr" rid="article-17997.r13">[13]</xref>&#x000a0;Under certain circumstances, a test and treat or single visit approach with VIA and colposcopy&#x000a0;showed to be preferred to Pap test, particularly in resource-limited settings.<xref ref-type="bibr" rid="article-17997.r79">[79]</xref><xref ref-type="bibr" rid="article-17997.r80">[80]</xref><xref ref-type="bibr" rid="article-17997.r70">[70]</xref><xref ref-type="bibr" rid="article-17997.r77">[77]</xref><xref ref-type="bibr" rid="article-17997.r66">[66]</xref><xref ref-type="bibr" rid="article-17997.r74">[74]</xref><xref ref-type="bibr" rid="article-17997.r67">[67]</xref><xref ref-type="bibr" rid="article-17997.r12">[12]</xref></p>
        <p>Apart from surgical interventions, certain pharmacological approaches have been employed under various randomized controlled trials (RCTs), with some showing promising outcomes at phase II.<xref ref-type="bibr" rid="article-17997.r81">[81]</xref><xref ref-type="bibr" rid="article-17997.r82">[82]</xref><xref ref-type="bibr" rid="article-17997.r83">[83]</xref><xref ref-type="bibr" rid="article-17997.r84">[84]</xref>&#x000a0;In one study done by G Laccetta and colleagues, 176 patients with ASC-US were treated with topical beta-glucan, and Pap test repeated after 6 months. Sixty-three percent reverted to a negative Pap test. No side effects were reported.<xref ref-type="bibr" rid="article-17997.r85">[85]</xref>&#x000a0;Cho et al. studied the effects of 1 to 1.5 g of oral poly-gamma-glutamic acid daily in 195 patients; and reported an HPV clearance rate of 44% in 85 patients with hrHPV.<xref ref-type="bibr" rid="article-17997.r82">[82]</xref>&#x000a0;In 1996, Manetta A and colleagues investigated the effects of a daily oral dose of beta carotenes in patients diagnosed with CIN 1 and 2. After 12 months of treatment, they reported as high as 60 percent regression of CIN1 in some of the patients.<xref ref-type="bibr" rid="article-17997.r86">[86]</xref>&#x000a0;Some other studies did not show positive effects on CIN lesions. Research conducted at the Medical College of Wisconsin explored the effects of 400 mg of daily oral celecoxib in 63 patients with CIN3. There was no positive change in the severity of the disease.<xref ref-type="bibr" rid="article-17997.r86">[86]</xref></p>
      </sec>
      <sec id="article-17997.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>ASC-US could represent different pathologies NILM, LSIL/CIN 1, HSIL/CIN 2+, or even early invasive cervical carcinoma. On the other hand, ASC-US&#x000a0;could be just a cytologic mimic caused by&#x000a0;inflammation (cervicitis), air drying, atrophy with degeneration, and other artifacts. True differentiation is best achieved with HPV DNA testing, colposcopy, and biopsy, particularly in persistent ASC-US.<xref ref-type="bibr" rid="article-17997.r55">[55]</xref><xref ref-type="bibr" rid="article-17997.r63">[63]</xref></p>
      </sec>
      <sec id="article-17997.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In the presence of quality triage studies, most ASC-US diagnoses have a good prognosis.<xref ref-type="bibr" rid="article-17997.r87">[87]</xref><xref ref-type="bibr" rid="article-17997.r88">[88]</xref>&#x000a0;Clearance of HPV infection returns the cervical tissues to normal. Still, progression to HSIL/CIN 2+ can be treated either by cryotherapy, LLETZ, or conization methods, and the patient stands a chance of complete lifetime elimination of the possibility of cancer.</p>
      </sec>
      <sec id="article-17997.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of ASC-US may arise from inadequate follow-up or the lack of it, or they may result from treatment in general. An ASC-US diagnosis may completely return to normal on repeat Pap test, but generally, an ASC-US diagnosis that is not followed up may worsen to HSIL/CIN 2+ or invasive cancer in underserved populations with limited or no access to comprehensive screening services.<xref ref-type="bibr" rid="article-17997.r23">[23]</xref><xref ref-type="bibr" rid="article-17997.r68">[68]</xref><xref ref-type="bibr" rid="article-17997.r23">[23]</xref>&#x000a0;In resource-limited settings, with unskilled staff, there is a risk of overtreatment of ASC-US/LSIL. All forms of treatment carry a very small risk of complications, ranging from mild pain during the procedure to bleeding, postoperative pain, and brownish vaginal discharge. Doing cryotherapy or LLETZ in the presence of cervicitis, bacterial vaginosis, or vaginal trichomoniasis may give rise to severe and malodorous vaginal discharge. Recurrence of the lesion may indicate poor quality treatment resulting from incomplete excision of lesion or transformation zone, though the presence of HPV is a stronger predictor of treatment failure. Preterm births have been reported to complicate the conization of the cervix in patients with CIN 2+ or AIS.<xref ref-type="bibr" rid="article-17997.r77">[77]</xref>&#x000a0;The persistence of lesions has also been reported to be more in HIV-infected patients compared to immunocompetent individuals.<xref ref-type="bibr" rid="article-17997.r89">[89]</xref></p>
      </sec>
      <sec id="article-17997.s13" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Patients treated with cryotherapy and LLETZ/LEEP are usually managed as day cases and are given mild oral analgesics such as ibuprofen. They are usually instructed to avoid sex for 4 to 6 weeks and to use condoms where abstinence fails. Patients are also advised not to insert tampons and not to douche. Those who develop malodorous discharge and or persistent vaginal discharge beyond 14 days are asked to return to the physician for reevaluation and treatment. Where signs of postoperative infection exist, endocervical or high vaginal swabs can be sent for culture, and the woman treated empirically with doxycycline 100 mg orally two times daily for seven days and metronidazole 400 mg orally three times a day for seven days.</p>
      </sec>
      <sec id="article-17997.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Full-blown advanced cervical cancer, whether in HIV-positive or negative women, has 100 percent mortality. All women should be made aware of the importance of regular screening and the availability of the HPV vaccine. Patients with nonspecific cervical abnormalities like ASC-US must be educated and closely monitored, so they do not fall through the cracks and later appear with invasive cervical cancer. Weigh the costs of screening for hrHPV and treating invasive cancer with attendant grave consequences on human lives and families; versus prevention. We should choose prevention over cure because it is a less expensive choice. Combined prevention and lifestyle modification, including delay in sexual debut, reduction of sexual partners, consistent and correct use of condoms, male circumcision, and smoking cessation, would go a long way to reduce precancer and cancer.</p>
      </sec>
      <sec id="article-17997.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="order">
          <list-item>
            <p>The coverage for cervical cancer screening in most resource-limited settings is still below 35 percent of the population.</p>
          </list-item>
          <list-item>
            <p>Women can be screened and followed up for cervical pre-malignant diseases, usually by Pap test, and also by VIA with colposcopy, HPV DNA, and biopsy.</p>
          </list-item>
          <list-item>
            <p>It is possible to do at least one cervical cancer screening method in any country in the world where cervical screening programs are not available. In 1949, Papanicolaou and Traut began doing simple cytology, and today we have&#x000a0;evolved to the more&#x000a0;sophisticated molecular DNA testing for HPV. There should be no excuse for not doing cervical cancer screening.</p>
          </list-item>
          <list-item>
            <p>Prioritizing and integrating cervical cancer screening in the daily management of women in primary healthcare facilities would go a long way to reducing new cases of cancer and possible elimination of deaths from invasive cervical cancer.</p>
          </list-item>
          <list-item>
            <p>ASC-US diagnosis is an abnormal finding that requires a further evaluation from 6 months after the initial result but not later than 12 months.</p>
          </list-item>
          <list-item>
            <p>An ASC-US diagnosis may mean NILM or true precancer and hence poses a management challenge, which needs to be addressed by triaging with molecular testing and histology.</p>
          </list-item>
          <list-item>
            <p>VIA (visual inspection with acetic acid), together with same-day treatment, has been shown to reduce the incidence of invasive cervical cancers.</p>
          </list-item>
          <list-item>
            <p>All patients with HIV must be prioritized to have a visual inspection with acetic acid. This is a simple and cheap procedure delivered as a screening and treating procedure or single visit approach.</p>
          </list-item>
          <list-item>
            <p>Large-scale HPV vaccination before the onset of sexual activity may hold the key to the elimination of cervical cancer.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17997.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Most women who would receive an ASC-US diagnosis are asymptomatic. Healthcare workers at primary care facilities, maternities, general outpatient departments, gynecology, and sexually transmitted infection (STI) clinics, need to be proactive, engage women, create awareness, and screen all sexually active women for cervical precancer. Healthcare professionals need to understand the interplay of culture, behavior, and socioeconomic status and their relationship to cervical cancer incidence.<xref ref-type="bibr" rid="article-17997.r23">[23]</xref>&#x000a0;Community health workers, nurses at immunization clinics, and midwives must be engaged to inform patients and create awareness on the benefits of cervical cancer screening and the dangers of invasive cervical cancer. The diagnosis and treatment of cervical precancer must be done in collaboration with skilled cytopathologists, gynecologic oncologists, and doctors specifically trained in cryotherapy, LLETZ, and conization.&#x000a0;Finally, prophylactic HPV vaccination in girls 9 to 15 years has been shown to have a huge decrease in new HPV infections.<xref ref-type="bibr" rid="article-17997.r90">[90]</xref>&#x000a0;Healthcare professions attending to female children and adolescent girls have ample opportunity to advocate for the scale-up of HPV vaccination across the globe.<xref ref-type="bibr" rid="article-17997.r90">[90]</xref><xref ref-type="bibr" rid="article-17997.r91">[91]</xref></p>
      </sec>
      <sec id="article-17997.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17997&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17997">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/atypical-squamous-cells-of-undetermined-significance-asc-us/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17997">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17997/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17997">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17997.s18">
        <title>References</title>
        <ref id="article-17997.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tewari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chaudhary</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Atypical Squamous Cells of Undetermined Significance : A Follow up Study.</article-title>
            <source>Med J Armed Forces India</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>66</volume>
            <issue>3</issue>
            <fpage>225</fpage>
            <page-range>225-7</page-range>
            <pub-id pub-id-type="pmid">27408306</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <collab>ASCUS-LSIL Traige Study (ALTS) Group</collab>
            <article-title>Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>188</volume>
            <issue>6</issue>
            <fpage>1383</fpage>
            <page-range>1383-92</page-range>
            <pub-id pub-id-type="pmid">12824967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arbyn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Castellsagu&#x000e9;</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>de Sanjos&#x000e9;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bruni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Saraiya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bray</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ferlay</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Worldwide burden of cervical cancer in 2008.</article-title>
            <source>Ann Oncol</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>22</volume>
            <issue>12</issue>
            <fpage>2675</fpage>
            <page-range>2675-2686</page-range>
            <pub-id pub-id-type="pmid">21471563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <collab>IARC Working Group on the Evaluation of Carcinogenic Risks to Humans</collab>
            <article-title>Human papillomaviruses.</article-title>
            <source>IARC Monogr Eval Carcinog Risks Hum</source>
            <year>2007</year>
            <volume>90</volume>
            <fpage>1</fpage>
            <page-range>1-636</page-range>
            <pub-id pub-id-type="pmid">18354839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dickinson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Stankiewicz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Popadiuk</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pogany</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Onysko</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006.</article-title>
            <source>BMC Public Health</source>
            <year>2012</year>
            <month>Nov</month>
            <day>16</day>
            <volume>12</volume>
            <fpage>992</fpage>
            <pub-id pub-id-type="pmid">23158654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rerucha</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Caro</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Wheeler</surname>
                <given-names>VL</given-names>
              </name>
            </person-group>
            <article-title>Cervical Cancer Screening.</article-title>
            <source>Am Fam Physician</source>
            <year>2018</year>
            <month>Apr</month>
            <day>01</day>
            <volume>97</volume>
            <issue>7</issue>
            <fpage>441</fpage>
            <page-range>441-448</page-range>
            <pub-id pub-id-type="pmid">29671553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eddy</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Screening for cervical cancer.</article-title>
            <source>Ann Intern Med</source>
            <year>1990</year>
            <month>Aug</month>
            <day>01</day>
            <volume>113</volume>
            <issue>3</issue>
            <fpage>214</fpage>
            <page-range>214-26</page-range>
            <pub-id pub-id-type="pmid">2115753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>US Preventive Services Task Force</collab>
              <name>
                <surname>Curry</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Krist</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Owens</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Caughey</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Doubeni</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Epling</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kemper</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Kubik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Landefeld</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Mangione</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Phipps</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Silverstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.</article-title>
            <source>JAMA</source>
            <year>2018</year>
            <month>Aug</month>
            <day>21</day>
            <volume>320</volume>
            <issue>7</issue>
            <fpage>674</fpage>
            <page-range>674-686</page-range>
            <pub-id pub-id-type="pmid">30140884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sawaya</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Huchko</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Cervical Cancer Screening.</article-title>
            <source>Med Clin North Am</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>101</volume>
            <issue>4</issue>
            <fpage>743</fpage>
            <page-range>743-753</page-range>
            <pub-id pub-id-type="pmid">28577624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirai</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Kaneshiro</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hiraoka</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>The Effect of the 2012 ASCCP Consensus Guideline for Abnormal Cervical Cytology on Resident Colposcopy Training.</article-title>
            <source>Hawaii J Med Public Health</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>77</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-6</page-range>
            <pub-id pub-id-type="pmid">29333334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wender</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Brawley</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>Fedewa</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Gansler</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>A blueprint for cancer screening and early detection: Advancing screening's contribution to cancer control.</article-title>
            <source>CA Cancer J Clin</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>69</volume>
            <issue>1</issue>
            <fpage>50</fpage>
            <page-range>50-79</page-range>
            <pub-id pub-id-type="pmid">30452086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Alessandro</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Arduino</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Borgo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saccone</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Venturella</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Di Cello</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zullo</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Loop Electrosurgical Excision Procedure versus Cryotherapy in the Treatment of Cervical Intraepithelial Neoplasia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.</article-title>
            <source>Gynecol Minim Invasive Ther</source>
            <year>2018</year>
            <season>Oct-Dec</season>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>145</fpage>
            <page-range>145-151</page-range>
            <pub-id pub-id-type="pmid">30306032</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castle</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Murokora</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Perez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quek</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Treatment of cervical intraepithelial lesions.</article-title>
            <source>Int J Gynaecol Obstet</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>138 Suppl 1</volume>
            <fpage>20</fpage>
            <page-range>20-25</page-range>
            <pub-id pub-id-type="pmid">28691333</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <collab>Committee on Practice Bulletins&#x02014;Gynecology</collab>
            <article-title>ACOG Practice Bulletin Number 131: Screening for cervical cancer.</article-title>
            <source>Obstet Gynecol</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>120</volume>
            <issue>5</issue>
            <fpage>1222</fpage>
            <page-range>1222-38</page-range>
            <pub-id pub-id-type="pmid">23090560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arbyn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weiderpass</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bruni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>de Sanjos&#x000e9;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saraiya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferlay</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bray</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.</article-title>
            <source>Lancet Glob Health</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>e191</fpage>
            <page-range>e191-e203</page-range>
            <pub-id pub-id-type="pmid">31812369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Philippe</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Is cervical cancer hereditary?</article-title>
            <source>Can Med Assoc J</source>
            <year>1981</year>
            <month>Mar</month>
            <day>15</day>
            <volume>124</volume>
            <issue>6</issue>
            <fpage>672</fpage>
            <page-range>672-6</page-range>
            <pub-id pub-id-type="pmid">20313553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>XM</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>JQ</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>In Vitro and In Vivo Synergistic Therapeutic Effect of Cisplatin with Human Papillomavirus16 E6/E7 CRISPR/Cas9 on Cervical Cancer Cell Line.</article-title>
            <source>Transl Oncol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>498</fpage>
            <page-range>498-504</page-range>
            <pub-id pub-id-type="pmid">27816686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of HPV and variation of HPV 16/HPV 18 E6/E7 genes in cervical cancer in women in South West China.</article-title>
            <source>J Med Virol</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>86</volume>
            <issue>11</issue>
            <fpage>1926</fpage>
            <page-range>1926-36</page-range>
            <pub-id pub-id-type="pmid">25111286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LINDSAY</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The Papanicolaou-Traut method of cancer diagnosis; its use as a routine pathologic laboratory procedure.</article-title>
            <source>Calif Med</source>
            <year>1949</year>
            <month>May</month>
            <volume>70</volume>
            <issue>5</issue>
            <fpage>413</fpage>
            <page-range>413-6</page-range>
            <pub-id pub-id-type="pmid">18126374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Austin</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Onisko</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Enhanced Detection of Cervical Cancer and Precancer Through Use of Imaged Liquid-Based Cytology in Routine Cytology and HPV Cotesting.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2018</year>
            <month>Oct</month>
            <day>01</day>
            <volume>150</volume>
            <issue>5</issue>
            <fpage>385</fpage>
            <page-range>385-392</page-range>
            <pub-id pub-id-type="pmid">30137189</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wright</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Stoler</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Behrens</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.</article-title>
            <source>Gynecol Oncol</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>136</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <page-range>189-97</page-range>
            <pub-id pub-id-type="pmid">25579108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gustavsson</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Aarnio</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Myrn&#x000e4;s</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hedlund-Lindberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Taku</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Meiring</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wikstr&#x000f6;m</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Enroth</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Williamson</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Olovsson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gyllensten</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening.</article-title>
            <source>Virol J</source>
            <year>2019</year>
            <month>Aug</month>
            <day>22</day>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>107</fpage>
            <pub-id pub-id-type="pmid">31438976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agurto</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Arrossi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Coffey</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dzuba</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bingham</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Involving the community in cervical cancer prevention programs.</article-title>
            <source>Int J Gynaecol Obstet</source>
            <year>2005</year>
            <month>May</month>
            <volume>89 Suppl 2</volume>
            <fpage>S38</fpage>
            <page-range>S38-45</page-range>
            <pub-id pub-id-type="pmid">15823265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al Eyd</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Shaik</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Rate of opportunistic pap smear screening and patterns of epithelial cell abnormalities in pap smears in ajman, United arab emirates.</article-title>
            <source>Sultan Qaboos Univ Med J</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>473</fpage>
            <page-range>473-8</page-range>
            <pub-id pub-id-type="pmid">23275844</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wysong</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Estep</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Besana</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kibwana</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Varallo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of Cervical Cancer Screening Programs in C&#x000f4;te d'Ivoire, Guyana, and Tanzania: Effect of HIV Status.</article-title>
            <source>PLoS One</source>
            <year>2015</year>
            <volume>10</volume>
            <issue>9</issue>
            <fpage>e0139242</fpage>
            <pub-id pub-id-type="pmid">26405784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kobetz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>XX</given-names>
              </name>
            </person-group>
            <article-title>New biological research and understanding of Papanicolaou's test.</article-title>
            <source>Diagn Cytopathol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>46</volume>
            <issue>6</issue>
            <fpage>507</fpage>
            <page-range>507-515</page-range>
            <pub-id pub-id-type="pmid">29663734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bukhari</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Saba</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Qamar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Majeed</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Niazi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Naeem</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinicopathological importance of Papanicolaou smears for the diagnosis of premalignant and malignant lesions of the cervix.</article-title>
            <source>J Cytol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>20</fpage>
            <page-range>20-5</page-range>
            <pub-id pub-id-type="pmid">22438612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perkins</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Guido</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Castle</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Chelmow</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Einstein</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Huh</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Moscicki</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Nayar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Saraiya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sawaya</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Wentzensen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Schiffman</surname>
                <given-names>M</given-names>
              </name>
              <collab>2019 ASCCP Risk-Based Management Consensus Guidelines Committee</collab>
            </person-group>
            <article-title>2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.</article-title>
            <source>J Low Genit Tract Dis</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>102</fpage>
            <page-range>102-131</page-range>
            <pub-id pub-id-type="pmid">32243307</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clifford</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Tully</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Franceschi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer.</article-title>
            <source>Clin Infect Dis</source>
            <year>2017</year>
            <month>May</month>
            <day>01</day>
            <volume>64</volume>
            <issue>9</issue>
            <fpage>1228</fpage>
            <page-range>1228-1235</page-range>
            <pub-id pub-id-type="pmid">28199532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saraiya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kwan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Primary HPV testing: U.S. women's awareness and acceptance of an emerging screening modality.</article-title>
            <source>Prev Med</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>108</volume>
            <fpage>111</fpage>
            <page-range>111-114</page-range>
            <pub-id pub-id-type="pmid">29277414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oliveira</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>JMDSC</given-names>
              </name>
              <name>
                <surname>Eleut&#x000e9;rio</surname>
                <given-names>RMN</given-names>
              </name>
              <name>
                <surname>Barbosa</surname>
                <given-names>RCC</given-names>
              </name>
              <name>
                <surname>Almeida</surname>
                <given-names>PRC</given-names>
              </name>
              <name>
                <surname>Eleut&#x000e9;rio</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Atypical Squamous Cells: Cytopathological Findings and Correlation with HPV Genotype and Histopathology.</article-title>
            <source>Acta Cytol</source>
            <year>2018</year>
            <volume>62</volume>
            <issue>5-6</issue>
            <fpage>386</fpage>
            <page-range>386-392</page-range>
            <pub-id pub-id-type="pmid">29898441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishimura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miyatake</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nakashima</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miyoshi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mimura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nagamatsu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ogita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yokoi</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Clinical Significance of Atypical Squamous Cells of Undetermined Significance among Patients Undergoing Cervical Conization.</article-title>
            <source>Asian Pac J Cancer Prev</source>
            <year>2015</year>
            <volume>16</volume>
            <issue>18</issue>
            <fpage>8145</fpage>
            <page-range>8145-7</page-range>
            <pub-id pub-id-type="pmid">26745052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gong</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dawlett</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bevers</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Sneige</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.</article-title>
            <source>Cancer Cytopathol</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>121</volume>
            <issue>2</issue>
            <fpage>79</fpage>
            <page-range>79-85</page-range>
            <pub-id pub-id-type="pmid">23225501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Torres-Ibarra</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cuzick</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lorincz</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Spiegelman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lazcano-Ponce</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Moscicki</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Mahmud</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Wheeler</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Rivera-Paredez</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez-L&#x000f3;pez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Le&#x000f3;n-Maldonado</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salmer&#x000f3;n</surname>
                <given-names>J</given-names>
              </name>
              <collab>FRIDA Study Group.</collab>
            </person-group>
            <article-title>Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.</article-title>
            <source>JAMA Netw Open</source>
            <year>2019</year>
            <month>Nov</month>
            <day>01</day>
            <volume>2</volume>
            <issue>11</issue>
            <fpage>e1915781</fpage>
            <pub-id pub-id-type="pmid">31747033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beyazit</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>S&#x00131;lan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gencer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aydin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Paksoy</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Unsal</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Ozdemir</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.</article-title>
            <source>Ginekol Pol</source>
            <year>2018</year>
            <volume>89</volume>
            <issue>2</issue>
            <fpage>62</fpage>
            <page-range>62-67</page-range>
            <pub-id pub-id-type="pmid">29512809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of carcinogenic HPV genotypes in North China Plain and the association with cervical lesions.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>98</volume>
            <issue>37</issue>
            <fpage>e17087</fpage>
            <pub-id pub-id-type="pmid">31517830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Lim-Tan</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Enhancement of early cervical cancer diagnosis with epithelial layer analysis of fluorescence lifetime images.</article-title>
            <source>PLoS One</source>
            <year>2015</year>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>e0125706</fpage>
            <pub-id pub-id-type="pmid">25966026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thrall</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Pambuccian</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Stelow</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>McKeon</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Savik</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gulbahce</surname>
                <given-names>HE</given-names>
              </name>
            </person-group>
            <article-title>Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.</article-title>
            <source>Cancer</source>
            <year>2008</year>
            <month>Jun</month>
            <day>25</day>
            <volume>114</volume>
            <issue>3</issue>
            <fpage>171</fpage>
            <page-range>171-9</page-range>
            <pub-id pub-id-type="pmid">18454461</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nayar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wilbur</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>The Bethesda System for Reporting Cervical Cytology: A Historical Perspective.</article-title>
            <source>Acta Cytol</source>
            <year>2017</year>
            <volume>61</volume>
            <issue>4-5</issue>
            <fpage>359</fpage>
            <page-range>359-372</page-range>
            <pub-id pub-id-type="pmid">28693017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sherman</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Schiffman</surname>
                <given-names>M</given-names>
              </name>
              <collab>ASCUS LSIL Triage Study Group</collab>
            </person-group>
            <article-title>Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2001</year>
            <month>Sep</month>
            <volume>116</volume>
            <issue>3</issue>
            <fpage>386</fpage>
            <page-range>386-94</page-range>
            <pub-id pub-id-type="pmid">11554167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dankai</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Khunamornpong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Siriaunkgul</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Soongkhaw</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Janpanao</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Utaipat</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kitkumthorn</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mutirangura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Srisomboon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lekawanvijit</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women.</article-title>
            <source>PLoS One</source>
            <year>2019</year>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>e0210289</fpage>
            <pub-id pub-id-type="pmid">30608989</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wright</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Stoler</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Parvu</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Yanson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Eckert</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kodsi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>CK</given-names>
              </name>
            </person-group>
            <article-title>Detection of Cervical Neoplasia by Human Papillomavirus Testing in an Atypical Squamous Cells-Undetermined Significance Population: Results of the Becton Dickinson Onclarity Trial.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2019</year>
            <month>Jan</month>
            <day>01</day>
            <volume>151</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-62</page-range>
            <pub-id pub-id-type="pmid">30189049</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nayar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wilbur</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>The Pap test and Bethesda 2014.</article-title>
            <source>Cancer Cytopathol</source>
            <year>2015</year>
            <month>May</month>
            <volume>123</volume>
            <issue>5</issue>
            <fpage>271</fpage>
            <page-range>271-81</page-range>
            <pub-id pub-id-type="pmid">25931431</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fujiwara</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morisawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sayama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The Impact of Triage for Atypical Squamous Cells of Undetermined Significance with Human Papillomavirus Testing in Cervical Cancer Screening in Japan.</article-title>
            <source>Asian Pac J Cancer Prev</source>
            <year>2019</year>
            <month>Jan</month>
            <day>25</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>81</fpage>
            <page-range>81-85</page-range>
            <pub-id pub-id-type="pmid">30678384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stoler</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Apple</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gutekunst</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>TL</given-names>
              </name>
              <collab>ATHENA (Addressing THE Need for Advanced HPV Diagnostics) HPV Study Group</collab>
            </person-group>
            <article-title>High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>135</volume>
            <issue>3</issue>
            <fpage>468</fpage>
            <page-range>468-75</page-range>
            <pub-id pub-id-type="pmid">21350104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jahic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jahic</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic Approach to Patients with Atypical Squamous Cells of Undetermined Significance Cytologic Findings on Cervix.</article-title>
            <source>Med Arch</source>
            <year>2016</year>
            <month>Jul</month>
            <day>27</day>
            <volume>70</volume>
            <issue>4</issue>
            <fpage>296</fpage>
            <page-range>296-298</page-range>
            <pub-id pub-id-type="pmid">27703293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhan</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Qiu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>[The role of HPV E6/E7 mRNA combined with P16/ki67 immunocytochemistry in the diagnosis of atypical squamous cells of undetermined significance(ASCUS)].</article-title>
            <source>Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>34</volume>
            <issue>10</issue>
            <fpage>937</fpage>
            <page-range>937-941</page-range>
            <pub-id pub-id-type="pmid">30554588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ki</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>Gen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.</article-title>
            <source>Int J Med Sci</source>
            <year>2019</year>
            <volume>16</volume>
            <issue>8</issue>
            <fpage>1096</fpage>
            <page-range>1096-1101</page-range>
            <pub-id pub-id-type="pmid">31523171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chalermchockcharoenkit</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chayachinda</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thamkhantho</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Komoltri</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: a 5.5-year retrospective cohort study.</article-title>
            <source>BMC Infect Dis</source>
            <year>2011</year>
            <month>Jan</month>
            <day>07</day>
            <volume>11</volume>
            <fpage>8</fpage>
            <pub-id pub-id-type="pmid">21211065</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kelly</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Benavente</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>de Sanjose</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mayaud</surname>
                <given-names>P</given-names>
              </name>
              <collab>ART and HPV Review Group</collab>
            </person-group>
            <article-title>Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.</article-title>
            <source>Lancet HIV</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>e45</fpage>
            <page-range>e45-e58</page-range>
            <pub-id pub-id-type="pmid">29107561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>George</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Baldassari</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez Taveras</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Jos&#x000e9; Fern&#x000e1;ndez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Concepci&#x000f3;n Robledo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The utility of pap cell block preparations with liqui-PREP&#x02122; cell pellets to clarify the cytological diagnosis of atypical squamous cells of undetermined significance and atypical glandular cells.</article-title>
            <source>Diagn Cytopathol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>520</fpage>
            <page-range>520-525</page-range>
            <pub-id pub-id-type="pmid">28342244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Solomon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Davey</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kurman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Moriarty</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Prey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Raab</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wilbur</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>N</given-names>
              </name>
              <collab>Forum Group Members</collab>
              <collab>Bethesda 2001 Workshop</collab>
            </person-group>
            <article-title>The 2001 Bethesda System: terminology for reporting results of cervical cytology.</article-title>
            <source>JAMA</source>
            <year>2002</year>
            <month>Apr</month>
            <day>24</day>
            <volume>287</volume>
            <issue>16</issue>
            <fpage>2114</fpage>
            <page-range>2114-9</page-range>
            <pub-id pub-id-type="pmid">11966386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stoler</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Schiffman</surname>
                <given-names>M</given-names>
              </name>
              <collab>Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group</collab>
            </person-group>
            <article-title>Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study.</article-title>
            <source>JAMA</source>
            <year>2001</year>
            <month>Mar</month>
            <day>21</day>
            <volume>285</volume>
            <issue>11</issue>
            <fpage>1500</fpage>
            <page-range>1500-5</page-range>
            <pub-id pub-id-type="pmid">11255427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abramovich</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Wasman</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Siekkinen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Abdul-Karim</surname>
                <given-names>FW</given-names>
              </name>
            </person-group>
            <article-title>Histopathologic correlation of atypical parakeratosis diagnosed on cervicovaginal cytology.</article-title>
            <source>Acta Cytol</source>
            <year>2003</year>
            <season>May-Jun</season>
            <volume>47</volume>
            <issue>3</issue>
            <fpage>405</fpage>
            <page-range>405-9</page-range>
            <pub-id pub-id-type="pmid">12789922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aoyama</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ostrzega</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Holschneider</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Histologic and immunohistochemical characteristics of neoplastic and nonneoplastic subgroups of atypical squamous lesions of the uterine cervix.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2005</year>
            <month>May</month>
            <volume>123</volume>
            <issue>5</issue>
            <fpage>699</fpage>
            <page-range>699-706</page-range>
            <pub-id pub-id-type="pmid">15981809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mariuzzi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Santinelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Valli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sisti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Montironi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mariuzzi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Alberti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pisani</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Cytometric evidence that cervical intraepithelial neoplasia I and II are dysplasias rather than true neoplasias. An image analysis study of factors involved in the progression of cervical lesions.</article-title>
            <source>Anal Quant Cytol Histol</source>
            <year>1992</year>
            <month>Apr</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>137</fpage>
            <page-range>137-47</page-range>
            <pub-id pub-id-type="pmid">1590897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ratree</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kleebkaow</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Aue-Aungkul</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Temtanakitpaisan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chumworathayi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Luanratanakorn</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Histopathology of Women with &#x0201c;Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion&#x0201d; (ASC-H) Smears.</article-title>
            <source>Asian Pac J Cancer Prev</source>
            <year>2019</year>
            <month>Mar</month>
            <day>26</day>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>683</fpage>
            <page-range>683-686</page-range>
            <pub-id pub-id-type="pmid">30909664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunyo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Effah</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Udofia</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Factors associated with late presentation of cervical cancer cases at a district hospital: a retrospective study.</article-title>
            <source>BMC Public Health</source>
            <year>2018</year>
            <month>Oct</month>
            <day>03</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>1156</fpage>
            <pub-id pub-id-type="pmid">30285699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McIntyre-Seltman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Castle</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Guido</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schiffman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wheeler</surname>
                <given-names>CM</given-names>
              </name>
              <collab>ALTS Group</collab>
            </person-group>
            <article-title>Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <year>2005</year>
            <month>May</month>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>1165</fpage>
            <page-range>1165-70</page-range>
            <pub-id pub-id-type="pmid">15894667</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lew</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Simms</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>XM</given-names>
              </name>
              <name>
                <surname>Caruana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Velentzis</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Bessell</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Saville</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hammond</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Canfell</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.</article-title>
            <source>Lancet Public Health</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>e96</fpage>
            <page-range>e96-e107</page-range>
            <pub-id pub-id-type="pmid">29253402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sankaranarayanan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Esmy</surname>
                <given-names>PO</given-names>
              </name>
              <name>
                <surname>Rajkumar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Muwonge</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Swaminathan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shanthakumari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fayette</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Cherian</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial.</article-title>
            <source>Lancet</source>
            <year>2007</year>
            <month>Aug</month>
            <day>04</day>
            <volume>370</volume>
            <issue>9585</issue>
            <fpage>398</fpage>
            <page-range>398-406</page-range>
            <pub-id pub-id-type="pmid">17679017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bruno</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Ferrara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fava</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Barrasso</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Panella</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>A prospective study of women with ASCUS or LSIL pap smears at baseline and HPV E6/E7 mRNA positive: a 3-year follow-up.</article-title>
            <source>Epidemiol Infect</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>146</volume>
            <issue>5</issue>
            <fpage>612</fpage>
            <page-range>612-618</page-range>
            <pub-id pub-id-type="pmid">29465024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luu</surname>
                <given-names>HN</given-names>
              </name>
              <name>
                <surname>Dahlstrom</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Mullen</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>VonVille</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Scheurer</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis.</article-title>
            <source>Cancer Med</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>367</fpage>
            <page-range>367-90</page-range>
            <pub-id pub-id-type="pmid">23930214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schiffman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kinney</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Gage</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Fetterman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Poitras</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Lorey</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Wentzensen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Befano</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schussler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Katki</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Castle</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.</article-title>
            <source>J Natl Cancer Inst</source>
            <year>2018</year>
            <month>May</month>
            <day>01</day>
            <volume>110</volume>
            <issue>5</issue>
            <fpage>501</fpage>
            <page-range>501-508</page-range>
            <pub-id pub-id-type="pmid">29145648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gage</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Zuna</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Schiffman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wentzensen</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>130</volume>
            <issue>6</issue>
            <fpage>1218</fpage>
            <page-range>1218-1225</page-range>
            <pub-id pub-id-type="pmid">29112672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Basu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Taghavi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Mogri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Management of cervical premalignant lesions.</article-title>
            <source>Curr Probl Cancer</source>
            <year>2018</year>
            <season>Mar-Apr</season>
            <volume>42</volume>
            <issue>2</issue>
            <fpage>129</fpage>
            <page-range>129-136</page-range>
            <pub-id pub-id-type="pmid">29428790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tai</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Chiang</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>You</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>WF</given-names>
              </name>
              <collab>Taiwan Cervical Cancer Control Task Force</collab>
            </person-group>
            <article-title>Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: a population-based cohort study.</article-title>
            <source>J Gynecol Oncol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>e55</fpage>
            <pub-id pub-id-type="pmid">29770625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Melnikow</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nuovo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Willan</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Howell</surname>
                <given-names>LP</given-names>
              </name>
            </person-group>
            <article-title>Natural history of cervical squamous intraepithelial lesions: a meta-analysis.</article-title>
            <source>Obstet Gynecol</source>
            <year>1998</year>
            <month>Oct</month>
            <volume>92</volume>
            <issue>4 Pt 2</issue>
            <fpage>727</fpage>
            <page-range>727-35</page-range>
            <pub-id pub-id-type="pmid">9764690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schlecht</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Platt</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Duarte-Franco</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Sobrinho</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Prado</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Ferenczy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rohan</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Villa</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.</article-title>
            <source>J Natl Cancer Inst</source>
            <year>2003</year>
            <month>Sep</month>
            <day>03</day>
            <volume>95</volume>
            <issue>17</issue>
            <fpage>1336</fpage>
            <page-range>1336-43</page-range>
            <pub-id pub-id-type="pmid">12953088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fokom Domgue</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Futuh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ngalla</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kakute</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Manjuh</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Manga</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nulah</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Welty</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schmeler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Welty</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Feasibility of a community-based cervical cancer screening with "test and treat" strategy using self-sample for an HPV test: Experience from rural Cameroon, Africa.</article-title>
            <source>Int J Cancer</source>
            <year>2020</year>
            <month>Jul</month>
            <day>01</day>
            <volume>147</volume>
            <issue>1</issue>
            <fpage>128</fpage>
            <page-range>128-138</page-range>
            <pub-id pub-id-type="pmid">31633801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bruno</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Coco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Di Pasqua</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bonanno</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Management of ASC-US/HPV positive post-menopausal woman.</article-title>
            <source>Virol J</source>
            <year>2019</year>
            <month>Mar</month>
            <day>28</day>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <pub-id pub-id-type="pmid">30922353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Egemen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Demarco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Perkins</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Kinney</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Poitras</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Befano</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Locke</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guido</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Wiser</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Gage</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Katki</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Wentzensen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Castle</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Schiffman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lorey</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.</article-title>
            <source>J Low Genit Tract Dis</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>132</fpage>
            <page-range>132-143</page-range>
            <pub-id pub-id-type="pmid">32243308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wyse</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Seah</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>O'Neill</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Byrne</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The use of cold coagulation for the treatment of cervical intraepithelial neoplasia.</article-title>
            <source>Ir Med J</source>
            <year>2017</year>
            <month>May</month>
            <day>10</day>
            <volume>110</volume>
            <issue>5</issue>
            <fpage>565</fpage>
            <pub-id pub-id-type="pmid">28737306</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoffman</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Le</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lockhart</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sanusi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dal Santo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McKinney</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Poole</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Willame</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic review.</article-title>
            <source>Int J Cancer</source>
            <year>2017</year>
            <month>Jul</month>
            <day>01</day>
            <volume>141</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-23</page-range>
            <pub-id pub-id-type="pmid">28124442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Staland</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Treatment of premalignant lesions of the uterine cervix by means of moderate heat thermosurgery using the SEMM coagulator.</article-title>
            <source>Ann Chir Gynaecol</source>
            <year>1978</year>
            <volume>67</volume>
            <issue>3</issue>
            <fpage>112</fpage>
            <page-range>112-6</page-range>
            <pub-id pub-id-type="pmid">686641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Langell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pickett</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mangum</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Langell</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Thermal Coagulation Device for Treating Cervical Dysplasia.</article-title>
            <source>Surg Innov</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>149</fpage>
            <page-range>149-152</page-range>
            <pub-id pub-id-type="pmid">30569837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kyrgiou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Athanasiou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kalliala</surname>
                <given-names>IEJ</given-names>
              </name>
              <name>
                <surname>Paraskevaidi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mitra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Martin-Hirsch</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Arbyn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Paraskevaidis</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Nov</month>
            <day>02</day>
            <volume>11</volume>
            <issue>11</issue>
            <fpage>CD012847</fpage>
            <pub-id pub-id-type="pmid">29095502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dolman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sauvaget</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Muwonge</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sankaranarayanan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Meta-analysis of the efficacy of cold coagulation as a treatment method for cervical intraepithelial neoplasia: a systematic review.</article-title>
            <source>BJOG</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>121</volume>
            <issue>8</issue>
            <fpage>929</fpage>
            <page-range>929-42</page-range>
            <pub-id pub-id-type="pmid">24597779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanghvi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Limpaphayom</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Plotkin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Charurat</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kleine</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Eamratsameekool</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Palanuwong</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Cervical cancer screening using visual inspection with acetic acid: operational experiences from Ghana and Thailand.</article-title>
            <source>Reprod Health Matters</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>16</volume>
            <issue>32</issue>
            <fpage>67</fpage>
            <page-range>67-77</page-range>
            <pub-id pub-id-type="pmid">19027624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phongsavan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Phengsavanh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wahlstr&#x000f6;m</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Marions</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Safety, feasibility, and acceptability of visual inspection with acetic acid and immediate treatment with cryotherapy in rural Laos.</article-title>
            <source>Int J Gynaecol Obstet</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>114</volume>
            <issue>3</issue>
            <fpage>268</fpage>
            <page-range>268-72</page-range>
            <pub-id pub-id-type="pmid">21752376</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rader</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sill</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Beumer</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lankes</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Benbrook</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Trimble</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tate Thigpen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lieberman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zuna</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Leath</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Spirtos</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Byron</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thaker</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Lele</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alberts</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.</article-title>
            <source>Gynecol Oncol</source>
            <year>2017</year>
            <month>May</month>
            <volume>145</volume>
            <issue>2</issue>
            <fpage>291</fpage>
            <page-range>291-297</page-range>
            <pub-id pub-id-type="pmid">28285845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cho</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Seong</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Short-term clinical and immunologic effects of poly-gamma-glutamic acid (&#x003b3;-PGA) in women with cervical intraepithelial neoplasia 1 (CIN 1): A multicenter, randomized, double blind, phase II trial.</article-title>
            <source>PLoS One</source>
            <year>2019</year>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>e0217745</fpage>
            <pub-id pub-id-type="pmid">31220105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hefler</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Grimm</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Speiser</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sliutz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Reinthaller</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The cyclooxygenase-2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II-III A phase II trial.</article-title>
            <source>Eur J Obstet Gynecol Reprod Biol</source>
            <year>2006</year>
            <month>Apr</month>
            <day>01</day>
            <volume>125</volume>
            <issue>2</issue>
            <fpage>251</fpage>
            <page-range>251-4</page-range>
            <pub-id pub-id-type="pmid">16188370</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ashrafian</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sukhikh</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kiselev</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Paltsev</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Drukh</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kuznetsov</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Muyzhnek</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Apolikhina</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Andrianova</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane's efficacy and safety in the treatment of CIN: implications for cervical cancer prevention.</article-title>
            <source>EPMA J</source>
            <year>2015</year>
            <volume>6</volume>
            <fpage>25</fpage>
            <pub-id pub-id-type="pmid">26693258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laccetta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Carrone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Burratti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mancino</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Effect of the treatment with &#x003b2;-glucan in women with cervical cytologic report of atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesions (L-SIL).</article-title>
            <source>Minerva Ginecol</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>113</fpage>
            <page-range>113-20</page-range>
            <pub-id pub-id-type="pmid">25668505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manetta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schubbert</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schell</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Liao</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Meyskens</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>beta-Carotene treatment of cervical intraepithelial neoplasia: a phase II study.</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <year>1996</year>
            <month>Nov</month>
            <volume>5</volume>
            <issue>11</issue>
            <fpage>929</fpage>
            <page-range>929-32</page-range>
            <pub-id pub-id-type="pmid">8922303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Verdoodt</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wentzensen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bergeron</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Arbyn</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer.</article-title>
            <source>Cancer Cytopathol</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>124</volume>
            <issue>4</issue>
            <fpage>261</fpage>
            <page-range>261-72</page-range>
            <pub-id pub-id-type="pmid">26618614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kisser</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zechmeister-Koss</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology.</article-title>
            <source>BJOG</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>122</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <page-range>64-70</page-range>
            <pub-id pub-id-type="pmid">25208923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yanik</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Napravnik</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cole</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Achenbach</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Gopal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Olshan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dittmer</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Kitahata</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Mugavero</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Saag</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mathews</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Eron</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.</article-title>
            <source>Clin Infect Dis</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>57</volume>
            <issue>5</issue>
            <fpage>756</fpage>
            <page-range>756-64</page-range>
            <pub-id pub-id-type="pmid">23735330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arbyn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Simoens</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Martin-Hirsch</surname>
                <given-names>PP</given-names>
              </name>
            </person-group>
            <article-title>Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2018</year>
            <month>May</month>
            <day>09</day>
            <volume>5</volume>
            <issue>5</issue>
            <fpage>CD009069</fpage>
            <pub-id pub-id-type="pmid">29740819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17997.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Monsonego</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues].</article-title>
            <source>Presse Med</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>36</volume>
            <issue>4 Pt 2</issue>
            <fpage>640</fpage>
            <page-range>640-66</page-range>
            <pub-id pub-id-type="pmid">17350792</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
